Real-Life Response to Biologics in Severe Asthma with Nasal Polyposis: Insights from the Belgian Severe Asthma Registry-Reference-Cited by-同舟云学术

Real-Life Response to Biologics in Severe Asthma with Nasal Polyposis: Insights from the Belgian Severe Asthma Registry

Published:2024-07-15 Issue:4 Volume:202 Page:441-448
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Demolder Femke,Vanderhelst Eef,Verbanck Sylvia,Schleich Florence,Louis Renaud,Brusselle Guy,Sohy Carine,Michils Alain,Peché Rudi,Pilette Charles,Hanon Shane

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00408-024-00715-0.pdf

Reference17 articles.

1. Canonica GW, Malvezzi L, Blasi F et al (2020) Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: evidences from the Severe Asthma Network Italy (SANI) registry. Respir Med 166:105947. https://doi.org/10.1016/j.rmed.2020.105947

2. Brusselle GG, Koppelman GH (2022) Biologic therapies for severe asthma. N Engl J Med 386(2):157–171. https://doi.org/10.1056/NEJMra2032506

3. Schleich F, Moermans C, Seidel L et al (2023) Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction - PROMISE. ERJ Open Res 9(6):00383–02023. https://doi.org/10.1183/23120541.00383-2023

4. Wautlet A, Bachert C, Desrosiers M, Hellings PW, Peters AT (2023) The management of chronic rhinosinusitis with nasal polyps (CRSwNP) with biologics. J Allergy Clin Immunol Pract 11(9):2642–2651. https://doi.org/10.1016/j.jaip.2023.04.054

5. Kolkhir P, Akdis CA, Akdis M et al (2023) Type 2 chronic inflammatory diseases: targets, therapies and unmet needs. Nat Rev Drug Discov 22(9):743–767. https://doi.org/10.1038/s41573-023-00750-1